Dr Zhi Ling Teo
Honorary Conjoint Fellow
The Sir Peter MacCallum Department of Oncology
17 Scholarly works
1 Projects
HIGHLIGHTS
2023
Journal article
Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer
DOI: 10.1038/s41523-023-00568-52023
Journal article
Tucatinib promotes immune activation and synergizes with programmed cell death-1 and programmed cell death-ligand 1 inhibition in HER2-positive breast cancer
DOI: 10.1093/jnci/djad0722023
Journal article
Intratumoral CD8 T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancer
DOI: 10.1016/j.ccell.2023.01.0042023
Conference Proceedings
SPEN is a biomarker for CDK4/6 inhibitor resistance in patients with metastatic hormone receptor positive (HR )/HER2-breast cancer
DOI: 10.1158/1538-7445.SABCS22-P5-02-162019
Conference Proceedings
Characterization of high TIL breast cancers reveals a prognostic and functionally distinct tissue-resident memory subpopulation
DOI: 10.1158/1538-7445.SABCS18-PD5-032018
Journal article
Is RNASEL: P.Glu265* a modifier of early-onset breast cancer risk for carriers of high-risk mutations?
DOI: 10.1186/s12885-018-4028-z2017
Journal article
Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer
DOI: 10.1038/s41467-017-00728-9
RECENT SCHOLARLY WORKS
2017
Journal article
Combined CDK4/6 and PI3Kα inhibition is synergistic and immunogenic in triple-negative breast cancer
DOI: 10.1158/0008-5472.CAN-17-22102016
Journal article
The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program “CASCADE”
DOI: 10.1371/journal.pmed.10022042016
Conference Proceedings
Specific targeting of the RAS/MAPK pathway in combination with immunotherapy promotes anti-tumor immune responses against triple negative breast cancers
RECENT PROJECTS
2016
Research Grant
Determining the Clinical Relevance of Intratumour Heterogeneity in Breast Cancer and Its Relationship to Metastases Formation